Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
Breast cancer is the most common type of malignancy and leading cause of cancer death among women worldwide. Despite the current revolutionary advances in the field of cancer immunotherapy, clinical response in breast cancer is frequently below expectations, in part due to various mechanisms of canc...
Saved in:
Main Authors: | Alba Navarro-Ocón (Author), Jose L. Blaya-Cánovas (Author), Araceli López-Tejada (Author), Isabel Blancas (Author), Rosario M. Sánchez-Martín (Author), María J. Garrido (Author), Carmen Griñán-Lisón (Author), Jesús Calahorra (Author), Francisca E. Cara (Author), Francisco Ruiz-Cabello (Author), Juan A. Marchal (Author), Natalia Aptsiauri (Author), Sergio Granados-Principal (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
by: Carmen Griñan-Lison, et al.
Published: (2021) -
Nanomedicines for Overcoming Cancer Drug Resistance
by: Tingting Hu, et al.
Published: (2022) -
Polycaprolactone Nanoparticles as Promising Candidates for Nanocarriers in Novel Nanomedicines
by: Sylwia Łukasiewicz, et al.
Published: (2021) -
Nanomedicine in cancer therapy: promises and hurdles of polymeric nanoparticles
by: Carmen Paus, et al.
Published: (2021) -
Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis
by: Poonam Negi, et al.
Published: (2019)